BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38622880)

  • 61. Confounding effect of cyclosporine dosing when comparing horse and rabbit antithymocyte globulin in patients with severe aplastic anemia.
    Bleyzac N; Philippe M; Bertrand A; Bertrand Y
    Haematologica; 2015 May; 100(5):e211-2. PubMed ID: 25944638
    [No Abstract]   [Full Text] [Related]  

  • 62. Answer to "Confounding effect of cyclosporine dosing when comparing horse and rabbit antithymocyte globulin in patients with severe aplastic anemia".
    Feng X; Scheinberg P; Young NS
    Haematologica; 2015 May; 100(5):e213. PubMed ID: 25944639
    [No Abstract]   [Full Text] [Related]  

  • 63. Rabbit-antithymocyte globulin combined with cyclosporin A as a first-line therapy: improved, effective, and safe for children with acquired severe aplastic anemia.
    Chen C; Xue HM; Xu HG; Li Y; Huang K; Zhou DH; Guo HX; Fang JP; Huang SL
    J Cancer Res Clin Oncol; 2012 Jul; 138(7):1105-11. PubMed ID: 22402596
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia.
    Filippidou M; Avgerinou G; Tsipou H; Tourkantoni N; Katsibardi K; Vlachou A; Roka K; Solomou E; Kattamis A
    Br J Haematol; 2020 Aug; 190(3):e157-e159. PubMed ID: 32529633
    [No Abstract]   [Full Text] [Related]  

  • 65. Horse versus rabbit antithymocyte globulin in immunosuppressive therapy of treatment-naïve aplastic anemia: a systematic review and meta-analysis.
    Yang N; Chen J; Zhang H; Dai Z; Yao H; Ma X; Bai J; Zhang Y; Zhang W
    Ann Hematol; 2017 Dec; 96(12):2031-2043. PubMed ID: 28965225
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Antilymphocyte globulin combining with cyclosporine A in the treatment of severe aplastic anemia].
    Zheng Y; Chu Y; Shao Z
    Zhonghua Xue Ye Xue Za Zhi; 1999 Apr; 20(4):175-7. PubMed ID: 11601221
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Markedly High Plasma Thrombopoietin (TPO) Level is a Predictor of Poor Response to Immunosuppressive Therapy in Children With Acquired Severe Aplastic Anemia.
    Elmahdi S; Muramatsu H; Narita A; Ismael O; Hama A; Nishio N; Okuno Y; Xu Y; Wang X; Takahashi Y; Kojima S
    Pediatr Blood Cancer; 2016 Apr; 63(4):659-64. PubMed ID: 26575027
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Combined antithymocyte globulin. cyclosporin. methylprednisolone and granulocyte colony-stimulating factor are effective in a patient with hepatitis-associated severe aplastic anemia].
    Kanakura M; Mihara H; Wakabayashi M; Tajima E; Hiramatsu A; Sato A; Imamura A; Miwa H; Kato Y; Nitta M
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91(3):1036-8. PubMed ID: 11985078
    [No Abstract]   [Full Text] [Related]  

  • 69. [Expression of HLA-DRB1*15 genotype in children with acquired aplastic anemia and its relation to effect of immunosuppressive therapy].
    Huang YL; Huang SL; Huang K; Bao R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1212-5. PubMed ID: 18088469
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.
    Peffault de Latour R; Kulasekararaj A; Iacobelli S; Terwel SR; Cook R; Griffin M; Halkes CJM; Recher C; Barraco F; Forcade E; Vallejo JC; Drexler B; Mear JB; Smith AE; Angelucci E; Raymakers RAP; de Groot MR; Daguindau E; Nur E; Barcellini W; Russell NH; Terriou L; Iori AP; La Rocca U; Sureda A; Sánchez-Ortega I; Xicoy B; Jarque I; Cavenagh J; Sicre de Fontbrune F; Marotta S; Munir T; Tjon JML; Tavitian S; Praire A; Clement L; Rabian F; Marano L; Hill A; Palmisani E; Muus P; Cacace F; Frieri C; van Lint MT; Passweg JR; Marsh JCW; Socié G; Mufti GJ; Dufour C; Risitano AM;
    N Engl J Med; 2022 Jan; 386(1):11-23. PubMed ID: 34986284
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.
    Marsh J; Schrezenmeier H; Marin P; Ilhan O; Ljungman P; McCann S; Socie G; Tichelli A; Passweg J; Hows J; Raghavachar A; Locasciulli A; Bacigalupo A
    Blood; 1999 Apr; 93(7):2191-5. PubMed ID: 10090926
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Respiratory and systemic infections in children with severe aplastic anemia on immunosuppressive therapy.
    Pawelec K; Salamonowicz M; Panasiuk A; Matysiak M; Demkow U
    Adv Exp Med Biol; 2013; 788():417-25. PubMed ID: 23836007
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.
    Frickhofen N; Heimpel H; Kaltwasser JP; Schrezenmeier H;
    Blood; 2003 Feb; 101(4):1236-42. PubMed ID: 12393680
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy of combination therapy with anti-thymocyte globulin and cyclosporine A as a first-line treatment in adult patients with aplastic anemia: a comparison of rabbit and horse formulations.
    Suzuki T; Kobayashi H; Kawasaki Y; Okazuka K; Hatano K; Fujiwara S; Oh I; Ohmine K; Kanda Y
    Int J Hematol; 2016 Oct; 104(4):446-53. PubMed ID: 27338268
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Different outcomes between cyclophosphamide plus horse or rabbit antithymocyte globulin for HLA-identical sibling bone marrow transplant in severe aplastic anemia.
    Atta EH; de Sousa AM; Schirmer MR; Bouzas LF; Nucci M; Abdelhay E
    Biol Blood Marrow Transplant; 2012 Dec; 18(12):1876-82. PubMed ID: 22796534
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Relapse of aplastic anemia responsive to sirolimus combined with cyclosporine.
    He G; Zhang X; Wu D; Sun A; Wang X
    Pediatr Blood Cancer; 2011 Jul; 56(7):1133-5. PubMed ID: 21488160
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
    Ganapiev AA; Golubovskaia IK; Zalialov IuR; Estrina MA; Afanas'ev BV
    Ter Arkh; 2010; 82(7):48-52. PubMed ID: 20853609
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hepatitis-associated aplastic anemia.
    Brown KE; Tisdale J; Barrett AJ; Dunbar CE; Young NS
    N Engl J Med; 1997 Apr; 336(15):1059-64. PubMed ID: 9091802
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.
    Kekre N; Zhang Y; Zhang MJ; Carreras J; Ahmed P; Anderlini P; Atta EH; Ayas M; Boelens JJ; Bonfim C; Deeg HJ; Kapoor N; Lee JW; Nakamura R; Pulsipher MA; Eapen M; Antin JH
    Haematologica; 2017 Jul; 102(7):1291-1298. PubMed ID: 28341733
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): an initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC).
    Williams DA; Bennett C; Bertuch A; Bessler M; Coates T; Corey S; Dror Y; Huang J; Lipton J; Olson TS; Reiss UM; Rogers ZR; Sieff C; Vlachos A; Walkovich K; Wang W; Shimamura A
    Pediatr Blood Cancer; 2014 May; 61(5):869-74. PubMed ID: 24285674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.